Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Rhea-AI Summary

Axogen (NASDAQ: AXGN), a leader in peripheral nerve function surgical solutions, has announced its participation in four major upcoming investor conferences in September 2025. The company will host a fireside chat at the Cantor Global Healthcare Conference on September 3 at 3:20 PM ET, which will be available via webcast.

Management will also conduct one-on-one investor meetings at the Wells Fargo Healthcare Conference (September 4), Morgan Stanley Annual Global Healthcare Conference (September 10), and Lake Street BIG 9 Conference (September 11). All webcast events will be accessible through Axogen's investor relations website and archived for 90 days.

ALACHUA, Fla. and TAMPA, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in four upcoming investor conferences:

Cantor Global Healthcare Conference (NYC)
Participation: Fireside chat and 1x1 investor meetings
Date/Time: Fireside Chat Wednesday, September 3, 2025, 3:20 PM ET
Webcast Link: Cantor/Axogen Fireside Chat

Wells Fargo Healthcare Conference (Boston)
Participation: 1x1 investor meetings only
Date/Time: Thursday, September 4, 2025

Morgan Stanley Annual Global Healthcare Conference (NYC)
Participation: 1x1 investor meetings only
Date/Time: Wednesday, September 10, 2025

Lake Street Best Ideas Growth (BIG 9) Conference (NYC)
Participation: 1x1 investor meetings only
Date/Time: Thursday, September 11, 2025

Webcast events can be accessed live through the Investors page at www.axogeninc.com. For those not available to listen to the live broadcast, the replay will be archived for 90 days and available through the Investors page on www.axogeninc.com.

About Axogen

Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

Axogen’s product portfolio includes Avance^® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard Nerve Connector^®, a porcine (pig) submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard Nerve Protector^®, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while minimizing soft tissue attachments; Axoguard HA+ Nerve Protector™, a porcine submucosa ECM base layer coated with a proprietary hyaluronate-alginate gel, a next-generation technology designed to enhance nerve gliding and provide short- and long-term protection for peripheral nerve injuries; Axoguard Nerve Cap^®, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive+ Soft Tissue Matrix™, a multi-layer amniotic membrane allograft used to protect and separate tissues in the surgical bed during the critical phase of tissue healing. The Axogen portfolio of products is available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea and several other countries.​

For more information, visit www.axogeninc.com

Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com

FAQ

When is Axogen's (AXGN) fireside chat at the Cantor Global Healthcare Conference 2025?

Axogen's fireside chat is scheduled for Wednesday, September 3, 2025, at 3:20 PM ET at the Cantor Global Healthcare Conference in New York City.

Which investor conferences will Axogen (AXGN) attend in September 2025?

Axogen will attend four conferences: Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), Morgan Stanley Annual Global Healthcare Conference (Sept 10), and Lake Street BIG 9 Conference (Sept 11).

How can investors access Axogen's (AXGN) conference presentations?

Investors can access the webcast events live through the Investors page at www.axogeninc.com. Replays will be archived for 90 days on the same website.

What type of meetings will Axogen (AXGN) conduct at the Wells Fargo Healthcare Conference?

At the Wells Fargo Healthcare Conference on September 4, 2025, Axogen will conduct one-on-one investor meetings only, with no public presentation scheduled.